Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-3-28
pubmed:abstractText
The benzoquinoid ansamycins geldanamycin (GA), herbimycin, and their derivatives are emerging as novel therapeutic agents that act by inhibiting the 90-kDa heat-shock protein hsp90. We report that GA inhibits the proliferation of mitogen-activated T cells. GA is actively toxic to both resting and activated T cells; activated T cells appear to be especially vulnerable. The mechanism by which GA acts is reflected by its effects on an essential hsp90-dependent protein, the T cell-specific nonreceptor tyrosine kinase lck. GA treatment depletes lck levels in cultured T cells by a kinetically slow dose-dependent process. Pulse-chase analyses indicate that GA induces the very rapid degradation of newly synthesized lck molecules. GA also induces a slower degradation of mature lck populations. These results correlate with global losses in protein tyrosine kinase activity and an inability to respond to TCR stimuli, but the activity of mature lck is not immediately compromised. Although the specific proteasome inhibitor lactacystin provides marginal protection against GA-induced lck depletion, proteasome inhibition also induces changes in lck detergent solubility independent of GA application. There is no other evidence for the involvement of the proteosome. Lysosome inhibition provides quantitatively superior protection against degradation. These results indicate that pharmacologic inhibition of hsp90 chaperone function may represent a novel immunosuppressant strategy, and elaborate on the appropriate context in which to interpret losses of lck as a reporter for the pharmacology of GA in whole organisms.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Benzoquinones, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Proteinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/HSP90 Heat-Shock Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lactams, Macrocyclic, http://linkedlifedata.com/resource/pubmed/chemical/Lymphocyte Specific Protein..., http://linkedlifedata.com/resource/pubmed/chemical/Mitogens, http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Quinones, http://linkedlifedata.com/resource/pubmed/chemical/geldanamycin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
164
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2915-23
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10706677-Animals, pubmed-meshheading:10706677-Benzoquinones, pubmed-meshheading:10706677-Cells, Cultured, pubmed-meshheading:10706677-Cysteine Endopeptidases, pubmed-meshheading:10706677-Cysteine Proteinase Inhibitors, pubmed-meshheading:10706677-Enzyme Inhibitors, pubmed-meshheading:10706677-HSP90 Heat-Shock Proteins, pubmed-meshheading:10706677-Humans, pubmed-meshheading:10706677-Immunosuppressive Agents, pubmed-meshheading:10706677-Jurkat Cells, pubmed-meshheading:10706677-Lactams, Macrocyclic, pubmed-meshheading:10706677-Lymphocyte Activation, pubmed-meshheading:10706677-Lymphocyte Specific Protein Tyrosine Kinase p56(lck), pubmed-meshheading:10706677-Male, pubmed-meshheading:10706677-Mice, pubmed-meshheading:10706677-Mice, Inbred DBA, pubmed-meshheading:10706677-Mitogens, pubmed-meshheading:10706677-Multienzyme Complexes, pubmed-meshheading:10706677-Proteasome Endopeptidase Complex, pubmed-meshheading:10706677-Protein Binding, pubmed-meshheading:10706677-Protein-Tyrosine Kinases, pubmed-meshheading:10706677-Quinones, pubmed-meshheading:10706677-Spleen, pubmed-meshheading:10706677-T-Lymphocytes, pubmed-meshheading:10706677-Time Factors
pubmed:year
2000
pubmed:articleTitle
Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
pubmed:affiliation
Department of Pediatrics, Steele Memorial Children's Research Center, University of Arizona, Tucson, AZ 85724, USA. pyorgin@stanford.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't